← Alle mensen

YM

Yasuo Miyoshi

3 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

KEYLYNK-009: Pembrolizumab plus Olaparib in Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer ...

Clinical cancer research : an official journal of the American Association for Cancer Research · 2 maart 2026

T-DXd versus physician's choice bij HER2-positief mammacarcinoom: DESTINY-Breast02 langetermijn

The Lancet. Oncology · 2024-05

T-DXd versus physician's choice bij HER2-positief mammacarcinoom: DESTINY-Breast02 fase III

Lancet (London, England) · 27 mei 2023